Related Links

Click here to go directly to the members only pages of the Health and Medicines Information Section.

Continuing Education

Click above to download the Counseling, Concordance, Communication booklet jointly produced with IPSF


Pharmabridge aims to strengthen pharmaceutical services and pharmacy education in developing and transitional countries. Click here to read more.

Health and Medicines Information Section

| About us | How we workAnnual Report 2017 | Activities |


Recently published FIP report on the strategic development of medicines information

A vision for the International Pharmaceutical Federation (FIP) and pharmacy organisations around the worldMedicines information: Strategic development” was published earlier this year. This report sets a vision for the International Pharmaceutical Federation (FIP) and pharmacy organisations around the world, as well as individual pharmacists, for a multidisciplinary collaborative and active approach towards high quality medicines information (processes and outcomes, for example leaflets) through well-planned, structured medicines information strategies that are embedded in national medicines policies. It defines and promotes the role of the pharmacist, within a multidisciplinary team, in the strategic development and implementation of national medicines information policies and practices.

The report stemmed from the efforts of FIP’s Health and Medicines Information Section (HaMIS) Working Group on National Strategic Plans for the Development and Use of Medicines Information, led by HaMIS member Dr Katri Hämeen-Anttila. The working group has been active since October 2012. The aim of this working group was to consider the key elements that should be included in a national strategic plan for medicines information and to identify practical steps that can be taken by pharmacists to strengthen medicines information development and provision in their home countries. Pharmacists should, ideally, be engaged — at all levels of practice — in promoting the role of the pharmacist in the strategic development and implementation of national medicines information policies and practices.
The working group has also been active in updating the FIP Policy Statement on medicines information based on the above mentioned report. The Policy Statement will be presented for adoption at the Council meeting that will take place later this year in Seoul, Republic of Korea. 

About us and our objective

FIP’s Health and Medicines Information Section (HaMIS; previously known as the Pharmacy Information Section) was founded in 1951 at FIP’s 14th general assembly in Rome. The membership has gradually broadened to include pharmacists and pharmaceutical scientists from all over the globe who are interested in information related to health and medicines across a number of different capacities.

A global map depicting the countries where the HaMIS members are from

HaMIS endeavours to offer:

  • A forum to share knowledge about information issues relating to pharmacy, medicines, medical conditions and health, including public health;
  • Avenues for networking between groups providing information and information services to patients and health care professionals;
  • Avenues for networking between groups conducting research related to health and medicines information; and
  • Opportunities to enhance public health and the work of the pharmacy profession through information programmes and related initiatives.

Health and medicines information underpins pharmacy practice across all disciplines. Areas of interest include:

  • Strategic development of medicines information;
  • Pharmacists as health and medicines information experts;
  • Information needs of health care professionals, patients and consumers; 
  • Development, dissemination, and use of health and medicines information to help optimise patient care, pharmaceutical care and public health;
  • Patient empowerment;
  • Health and medicines information as a tool to improve medication adherence;
  • Health literacy;
  • Development of health information technology and information delivery;
  • Novel formats of health care communication, inclusive of social media, mHealth, Internet resources and other electronic resources;
  • Writing and publishing health and medicines information resources;
  • Medicine and poisons information services;
  • Pharmacovigilance efforts;
  • Global access to health care information;
  • Medicines formulary information development; and
  • Advertising and promotion of medicines.

How we work

Every four years, officers of FIP’s Health and Medicines Information Section (HaMIS) are elected. They include a president, secretary and treasurer. The Executive Committee consists of these three officers, the immediate past president, and three to six section members elected to provide geographical balance. The current Executive Committee (2016-20) comprises the following members:


Prof. Parisa Aslani


Dr Boyan Todorov


Ms Lindsay McClure
(United Kingdom)

Representative for
Africa/ Middle East

Mr Wael Kamel Ali Ali Mazrouh

Representative for the Americas

Prof. Victoria Hall Ramírez
(Costa Rica)

Representative for Asia/Pacific

Dr Vivien Tong

Representative for Europe

Ms Rian Lelie- van der Zande

In addition to these positions, there are two representative-at-large positions, which do not necessarily represent a certain region of the world. Both positions are currently vacant and there will be a call for nominations at the 2017 FIP annual world congress in Seoul.

The current statutes of the Health and Medicines Information Section were adopted by the FIP Council in 2014. Click to download the HaMIS statutes in PDF format.